文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

儿童和青少年长新冠的患病率及危险因素:一项荟萃分析和系统综述。

Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review.

机构信息

Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Peking University, Beijing, China; Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.

National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China; School of Public Health, Peking University, Beijing, China; Beijing Friendship Hospital, Capital Medical University, Beijing, China.

出版信息

J Infect Public Health. 2023 May;16(5):660-672. doi: 10.1016/j.jiph.2023.03.005. Epub 2023 Mar 7.


DOI:10.1016/j.jiph.2023.03.005
PMID:36931142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9990879/
Abstract

BACKGROUND: Millions of COVID-19 pediatric survivors are facing the risk of long COVID after recovery from acute COVID-19. The primary objective of this study was to systematically review the available literature and determine the pooled prevalence of, and risk factors for long COVID among the pediatric survivors. METHODS: Studies that assessed the prevalence of, or risk factors associated with long COVID among pediatric COVID-19 survivors were systematically searched in PubMed, Embase, and Cochrane Library up to December 11th, 2022. Random effects model was performed to estimate the pooled prevalence of long COVID among pediatric COVID-19 patients. Subgroup analyses and meta-regression on the estimated prevalence of long COVID were performed by stratification with follow-up duration, mean age, sex ratio, percentage of multisystem inflammatory syndrome, hospitalization rate at baseline, and percentage of severe illness. RESULTS: Based on 40 studies with 12,424 individuals, the pooled prevalence of any long COVID was 23.36 % ([95 % CI 15.27-32.53]). The generalized symptom (19.57 %, [95 % CI 9.85-31.52]) was reported most commonly, followed by respiratory (14.76 %, [95 % CI 7.22-24.27]), neurologic (13.51 %, [95 % CI 6.52-22.40]), and psychiatric (12.30 %, [95% CI 5.38-21.37]). Dyspnea (22.75 %, [95% CI 9.38-39.54]), fatigue (20.22 %, [95% CI 9.19-34.09]), and headache (15.88 %, [95 % CI 6.85-27.57]) were most widely reported specific symptoms. The prevalence of any symptom during 3-6, 6-12, and> 12 months were 26.41 % ([95 % CI 14.33-40.59]), 20.64 % ([95 % CI 17.06-24.46]), and 14.89 % ([95 % CI 6.09-26.51]), respectively. Individuals with aged over ten years, multisystem inflammatory syndrome, or had severe clinical symptoms exhibited higher prevalence of long COVID in multi-systems. Factors such as older age, female, poor physical or mental health, or had severe infection or more symptoms were more likely to have long COVID in pediatric survivors. CONCLUSIONS: Nearly one quarter of pediatric survivors suffered multisystem long COVID, even at 1 year after infection. Ongoing monitoring, comprehensive prevention and intervention is warranted for pediatric survivors, especially for individuals with high risk factors.

摘要

背景:数百万 COVID-19 儿科幸存者在急性 COVID-19 康复后面临长新冠的风险。本研究的主要目的是系统地回顾现有文献,确定儿科 COVID-19 幸存者的长新冠总体患病率和风险因素。

方法:系统检索了 PubMed、Embase 和 Cochrane Library 中截至 2022 年 12 月 11 日评估儿科 COVID-19 幸存者长新冠患病率或与长新冠相关的风险因素的研究。采用随机效应模型估计儿科 COVID-19 患者长新冠的总体患病率。通过分层进行亚组分析和对长新冠估计患病率的荟萃回归,分层因素包括随访时间、平均年龄、性别比、多系统炎症综合征百分比、基线住院率和严重疾病百分比。

结果:基于 40 项研究共 12424 人,任何长新冠的总体患病率为 23.36%(95%CI 15.27-32.53)。最常见的是广义症状(19.57%,95%CI 9.85-31.52),其次是呼吸系统症状(14.76%,95%CI 7.22-24.27)、神经系统症状(13.51%,95%CI 6.52-22.40)和精神科症状(12.30%,95%CI 5.38-21.37)。最广泛报道的特定症状是呼吸困难(22.75%,95%CI 9.38-39.54)、疲劳(20.22%,95%CI 9.19-34.09)和头痛(15.88%,95%CI 6.85-27.57)。在 3-6 个月、6-12 个月和>12 个月时,任何症状的患病率分别为 26.41%(95%CI 14.33-40.59)、20.64%(95%CI 17.06-24.46)和 14.89%(95%CI 6.09-26.51)。年龄在 10 岁以上、有多系统炎症综合征或有严重临床症状的个体在多系统中表现出更高的长新冠患病率。年龄较大、女性、身体或精神健康状况较差、或感染严重或症状较多的个体更有可能成为儿科幸存者中的长新冠患者。

结论:近四分之一的儿科幸存者患有多系统长新冠,即使在感染后 1 年也是如此。需要对儿科幸存者进行持续监测、全面预防和干预,特别是对有高风险因素的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/db7ad689445c/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/18d14fdf8e6a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/c0cd5128a100/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/6a1e7cd99b61/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/46e6891a491e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/db7ad689445c/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/18d14fdf8e6a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/c0cd5128a100/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/6a1e7cd99b61/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/46e6891a491e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1bc/9990879/db7ad689445c/gr5_lrg.jpg

相似文献

[1]
Prevalence and risk factor for long COVID in children and adolescents: A meta-analysis and systematic review.

J Infect Public Health. 2023-5

[2]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[3]
A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action.

Mol Psychiatry. 2023-1

[4]
Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.

Respir Res. 2022-9-6

[5]
A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.

J Med Virol. 2023-6

[6]
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.

Clin Microbiol Infect. 2022-5

[7]
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.

Lancet Respir Med. 2022-9

[8]
Post-COVID syndrome prevalence: a systematic review and meta-analysis.

BMC Public Health. 2024-7-4

[9]
Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.

Clin Microbiol Infect. 2024-3

[10]
Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.

PLoS One. 2024

引用本文的文献

[1]
The healthcare burden imposed by children with gastroparesis and the shift imposed by COVID-19.

Front Pediatr. 2025-7-22

[2]
Perceptions and Significance of Long Covid Diagnoses From the Perspectives of Children and Young People With Long Covid, Their Parents and Professionals.

Health Expect. 2025-6

[3]
SARS-CoV-2 seroprevalence among learners in grades 1-7, their parents and teachers in KwaZulu-Natal, South Africa: a cross-sectional study.

Front Public Health. 2025-5-2

[4]
The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies.

Nat Commun. 2025-5-7

[5]
Long COVID in pediatric age: an observational, prospective, longitudinal, multicenter study in Italy.

Front Immunol. 2025-4-9

[6]
Association of School Social Status with COVID-19 Pandemic-Related Changes and Post-Pandemic Rebounds of Children's Physical Fitness.

Sports Med Open. 2025-4-23

[7]
Cognitive behavioural therapy for severe fatigue following COVID-19 in adolescents: a serial single-case observational study of five consecutively referred patients.

Behav Cogn Psychother. 2025-4-22

[8]
Role of nutrient supplements in children with post-COVID condition: a retrospective preliminary observation and narrative review.

Ital J Pediatr. 2025-4-16

[9]
Pediatric Long COVID Subphenotypes: An EHR-based study from the RECOVER program.

PLOS Digit Health. 2025-4-10

[10]
Cumulative social disadvantage and its impact on long COVID: insights from a U.S. national survey.

BMC Med. 2025-4-7

本文引用的文献

[1]
The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China.

Mol Psychiatry. 2023-4

[2]
Predictive model for long COVID in children 3 months after a SARS-CoV-2 PCR test.

BMC Med. 2022-11-30

[3]
The Prevalence, Characteristics and Risk Factors of Persistent Symptoms in Non-Hospitalized and Hospitalized Children with SARS-CoV-2 Infection Followed-Up for up to 12 Months: A Prospective, Cohort Study in Rome, Italy.

J Clin Med. 2022-11-16

[4]
Extended coagulation profile of children with Long Covid: a prospective study.

Sci Rep. 2022-11-1

[5]
Comparison of Long-Term Complications of COVID-19 Illness among a Diverse Sample of Children by MIS-C Status.

Int J Environ Res Public Health. 2022-10-17

[6]
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.

JAMA. 2022-10-25

[7]
A non-randomized comparative study of olfactory and gustatory functions in children who recovered from COVID-19 (1-year follow-up).

Front Pediatr. 2022-9-9

[8]
Pulmonary Dysfunction after Pediatric COVID-19.

Radiology. 2023-3

[9]
Neurological and psychological effects of long COVID in a young population: A cross-sectional study.

Front Neurol. 2022-8-17

[10]
Multisystem inflammatory syndrome in children: clinical presentation, management, and short- and long-term outcomes.

Clin Rheumatol. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索